comparemela.com

Latest Breaking News On - Glaxosmithkline benlysta - Page 1 : comparemela.com

IMMUPHARMA AT BIO-EQUITY 2024 12-14 May | Company Announcement

Major Shifts in Management of Patients with Lupus Nephritis Spurred by Availability of Aurinia Pharmaceutical's Lupkynis and GSK's Benlysta, According to Spherix Global Insights

/PRNewswire/ With the approvals of GlaxoSmithKline s Benlysta (belimumab) in lupus nephritis (LN) at the end of 2020 and Aurinia s Lupkynis (voclosporin) at.

Novarti-cosentyx
Astrazeneca-saphnelo
Glaxosmithkline-benlysta
Scott-upham
Roche-genentech-gazyva
Aurinia-lupkynis
Bryan-rex
Janssen-tremfya
Corporate-communications
Spherix-network
Spherix-global-insights
Global-insights

vimarsana © 2020. All Rights Reserved.